Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges

In cancer patients, loss of muscle mass is significantly associated with low tolerability of chemotherapy and poor survival. Despite the great strides in the treatment of cancer, targeted therapies such as tyrosine kinase inhibitors (TKIs) could exacerbate muscle wasting. Over recent years, the impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinninella, Emanuele, Cintoni, Marco, Raoul, Pauline, Pozzo, Carmelo, Strippoli, Antonia, Ponziani, Francesca Romana, Pompili, Maurizio, Bria, Emilio, Tortora, Giampaolo, Gasbarrini, Antonio, Mele, Maria Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601327/
https://www.ncbi.nlm.nih.gov/pubmed/33053632
http://dx.doi.org/10.3390/nu12103101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601327/
https://www.ncbi.nlm.nih.gov/pubmed/33053632
http://dx.doi.org/10.3390/nu12103101

Ejemplares similares